{
     "PMID": "17785179",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20071101",
     "LR": "20131121",
     "IS": "0896-6273 (Print) 0896-6273 (Linking)",
     "VI": "55",
     "IP": "5",
     "DP": "2007 Sep 6",
     "TI": "Serotonin(4) (5-HT(4)) receptor agonists are putative antidepressants with a rapid onset of action.",
     "PG": "712-25",
     "AB": "Current antidepressants are clinically effective only after several weeks of administration. Here, we show that serotonin(4) (5-HT(4)) agonists reduce immobility in the forced swimming test, displaying an antidepressant potential. Moreover, a 3 day regimen with such compounds modifies rat brain parameters considered to be key markers of antidepressant action, but that are observed only after 2-3 week treatments with classical molecules: desensitization of 5-HT(1A) autoreceptors, increased tonus on hippocampal postsynaptic 5-HT(1A) receptors, and enhanced phosphorylation of the CREB protein and neurogenesis in the hippocampus. In contrast, a 3 day treatment with the SSRI citalopram remains devoid of any effect on these parameters. Finally, a 3 day regimen with the 5-HT(4) agonist RS 67333 was sufficient to reduce both the hyperlocomotion induced by olfactory bulbectomy and the diminution of sucrose intake consecutive to a chronic mild stress. These findings point out 5-HT(4) receptor agonists as a putative class of antidepressants with a rapid onset of action.",
     "FAU": [
          "Lucas, Guillaume",
          "Rymar, Vladimir V",
          "Du, Jenny",
          "Mnie-Filali, Ouissame",
          "Bisgaard, Christina",
          "Manta, Stella",
          "Lambas-Senas, Laura",
          "Wiborg, Ove",
          "Haddjeri, Nasser",
          "Pineyro, Graciela",
          "Sadikot, Abbas F",
          "Debonnel, Guy"
     ],
     "AU": [
          "Lucas G",
          "Rymar VV",
          "Du J",
          "Mnie-Filali O",
          "Bisgaard C",
          "Manta S",
          "Lambas-Senas L",
          "Wiborg O",
          "Haddjeri N",
          "Pineyro G",
          "Sadikot AF",
          "Debonnel G"
     ],
     "AD": "Universite McGill, Departement de Psychiatrie, Batiment de Recherche et de Formation, Bureau 207, 1033 Avenue des Pins Ouest, Montreal, QC, H3A 1A1 Canada. guillaume.lucas@gmail.com",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "PL": "United States",
     "TA": "Neuron",
     "JT": "Neuron",
     "JID": "8809320",
     "RN": [
          "0 (Aniline Compounds)",
          "0 (Antidepressive Agents)",
          "0 (Cyclic AMP Response Element-Binding Protein)",
          "0 (Piperidines)",
          "0 (Serotonin 5-HT1 Receptor Agonists)",
          "0 (Serotonin 5-HT4 Receptor Agonists)",
          "0 (Serotonin Receptor Agonists)",
          "0 (Serotonin Uptake Inhibitors)",
          "112692-38-3 (Receptor, Serotonin, 5-HT1A)",
          "158165-40-3 (Receptors, Serotonin, 5-HT4)",
          "160845-95-4 (RS 67333)",
          "333DO1RDJY (Serotonin)"
     ],
     "SB": "IM",
     "CIN": [
          "Neuron. 2007 Sep 6;55(5):679-81. PMID: 17785173"
     ],
     "MH": [
          "Aniline Compounds/pharmacology/therapeutic use",
          "Animals",
          "Antidepressive Agents/*pharmacology/therapeutic use",
          "Brain/*drug effects/metabolism/physiopathology",
          "Cyclic AMP Response Element-Binding Protein/drug effects/metabolism",
          "Depressive Disorder/*drug therapy/metabolism/physiopathology",
          "Disease Models, Animal",
          "Hippocampus/drug effects/metabolism/physiopathology",
          "Male",
          "Motor Activity/drug effects/physiology",
          "Phosphorylation/drug effects",
          "Piperidines/pharmacology/therapeutic use",
          "Rats",
          "Rats, Sprague-Dawley",
          "Reaction Time/drug effects/physiology",
          "Receptor, Serotonin, 5-HT1A/metabolism",
          "Receptors, Serotonin, 5-HT4/metabolism",
          "Serotonin/*metabolism",
          "Serotonin 5-HT1 Receptor Agonists",
          "*Serotonin 5-HT4 Receptor Agonists",
          "Serotonin Receptor Agonists/*pharmacology/therapeutic use",
          "Serotonin Uptake Inhibitors/pharmacology",
          "Stress, Psychological/drug therapy/metabolism/physiopathology",
          "Time Factors"
     ],
     "EDAT": "2007/09/06 09:00",
     "MHDA": "2007/11/02 09:00",
     "CRDT": [
          "2007/09/06 09:00"
     ],
     "PHST": [
          "2005/08/12 00:00 [received]",
          "2006/07/24 00:00 [revised]",
          "2007/07/29 00:00 [accepted]",
          "2007/09/06 09:00 [pubmed]",
          "2007/11/02 09:00 [medline]",
          "2007/09/06 09:00 [entrez]"
     ],
     "AID": [
          "S0896-6273(07)00618-6 [pii]",
          "10.1016/j.neuron.2007.07.041 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Neuron. 2007 Sep 6;55(5):712-25. doi: 10.1016/j.neuron.2007.07.041.",
     "term": "hippocampus"
}